ArticleDrug safety2021

Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry.

Alexandra Simbrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.